We're thrilled to invite you to this new webinar, hosted in partnership with Greenlight Guru, on the evolution and current state of Laboratory Developed Tests (LDTs) following the FDA's recent final rule announcement. 📅 Date: Thursday, June 20 🕒 Time: 1:00 to 2:30 PM ET 🔗 Link: https://lnkd.in/g8YsdXE5 Join Carol Buchert, Sruthi Sundaram, PhD, RAC, and Etienne Nichols as they dive into the implications for labs transitioning their LDTs into IVDs, cover exemp devices, and discuss continued enforcement discretion. #laboratory #lab #microbiology #chemistrylab #lablife #ivd #medicaldevices #ldt #fda
MDC Associates, Inc.’s Post
More Relevant Posts
-
Catch up with the latest Cresset news in our March newsletter, where we share our latest results for GPCR benchmarks using Flare™ FEP along with all our latest updates including: 🏆 Cresset wins Bionow Internationalisation Award 💻 Webinar 'Enhancing collaboration in drug discovery - a biotech perspective' 📢 Speaker announcements for our Cresset User Group Meeting in June ⚡ Solutions for virtual screening enumerated libraries and combinatorial spaces https://obi41.nl/4eaxy5ms For monthly updates direct to your inbox, subscribe to our newsletter at the above link and be the first to hear about our latest news, case studies, expert scientific opinion and events to support you with your small molecule discovery. #DMTA #drugdiscovery #drugdesign #computationalchemistry #compchem #medicinalchemistry #medchem #CADD #preclinicalresearch
To view or add a comment, sign in
-
Partner at Sidley Austin LLP || Co-founder Women Life Sciences Network (WLSN) || Advisory Board Member W@LifeSciences
🤔 Wondering how the FDA's Final Rule on Laboratory Developed Tests might impact you? Colleagues Torrey Cope, Sean Griffin and Frank Rahmani consider Four Strategic Questions in this article 💡
Partner and Global Leader of the Food, Drug, and Medical Device Compliance and Enforcement Group at Sidley Austin LLP
FDA’s long-anticipated final rule on Laboratory-Developed Tests is out. Sidley’s Life Sciences Team has a detailed analysis of the key strategic questions related to the rule.
To view or add a comment, sign in
-
Achieving Rapid #LC-MS Analyses Using #Avantor® #ACE® #HTP-MS #Columns Achieving fast LC analyses is essential in high sample throughput laboratories, such as clinical, drug discovery and environmental labs. Over the last two decades, #UHPLC has enabled many labs to dramatically increase sample throughput, through use of shorter columns packed with sub-2 micron particles. However, at the same time, the performance of modern mass spectrometers has continued to evolve. Improved sensitivity and ultra-fast data acquisition capabilities, provide opportunities to further reduce analytical run times, using specially designed, high throughput columns. This #webinar begins by discussing the concepts of how to develop high throughput LC-MS methods, before introducing the Avantor® ACE® HTP-MS column. The use of this column format to develop ultra-fast LC-MS analyses will be discussed, along with several key applications that demonstrate the advantages that can be realised. Finally, some of the challenges associated with rapid analysis will be discussed, including aspects of sample preparation and the impact the matrix can have on the detector. For more information, please contact us at [email protected] #REGISTER NOW! https://lnkd.in/dpZ-yFhs
Achieving Rapid LC-MS Analyses Using Avantor® ACE® HTP-MS Columns
it.vwr.com
To view or add a comment, sign in
-
It is known that Biolayer interferometry (BLI) is an optical biosensor method for real-time, label-free analysis of biomolecular interactions (kinetic analyses, analyte detection and quantitation). However, not everyone knows BLI can support diverse activities of drug discovery and development, ranging from compound library screening, structure-activity relationship and selectivity analyses of small-molecule drug leads, to cell line development, optimization, characterization and QC. Today, I was surprised to find that the performance of Gator Bio’s biosensors has been improved to a new level which has once again broken the record. #BLI #GatorBio #LabelFree #BiomolecularInteraction #Kinetic #Quantitation #Detection #DrugDiscovery #Screening #CLD #QC
To view or add a comment, sign in
-
-
June 2024 NIAID Council-Approved CCRP Concept (proposed FY 2025 initiative) - Notice of Special Interest (NOSI): R13 Support for an Annual Scientific Meeting to Support the Chemical Countermeasures Research Program (#NIAIDCCRP) Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council’s input. Note: Council approval does not guarantee that a concept will become an initiative. #healthpreparedness, #healthsecurity, #MCMs, #chemicaltoxicity
June 2024 Trans-Divisional Council-Approved Concepts
niaid.nih.gov
To view or add a comment, sign in
-
Just a few days away from ACoP14 and we are longing to meet you there 😃! We will have several activities this year: workshops, poster presentations, co-sharing a scientific session, speed consulting and speed advising for students and of course a booth where we warmly invite you to visit. While visiting our booth you can be part of our CSR activity - come by and we will tell you more about that! Link to more information about all our activities at ACoP can be found in the comments. #ACoP # #pharmacometrics #pharmacokinetics #lifesciences
To view or add a comment, sign in
-
-
Looking forward to the insightful talks from my colleagues of CMC statistics experts, Bruno Boulanger and Pierre Lebrun in the upcoming IFPAC 2024 conference! #pharmaindustry #manufacturing #CMC #statistics
🌟 Join us at IFPAC 2024: Navigating the Future of Advanced Manufacturing! 🚀 📍 Mark your calendars for March 3-6, 2024, at Bethesda North Marriott in N. Bethesda, MD. Don't miss the insightful Cencora PharmaLex Speakers Sessions: Bruno Boulanger - Global Head Statistics and Data Science: 🎙️Session 1: Wed, March 06 | 7:50 AM – 12:00 PM "Reliably Assessing Comparability in Autologous Cell Therapy Change Protocols: A Compliance Perspective" 🎙️Session 2: March 06 | 7:50 AM – 12:00 PM "Exploring the Impact of ICH-Q2(R2) and ICH-Q14 Introduction of ATP and Total Analytical Error on PAT Measurement Validation and Product Quality" Pierre Lebrun - Director Statistics: 🎙️Session: March 06 | 1:05 PM – 5:40 PM "Design Space for Formulation Development and Drug Product Stability Conference Center: Forest Glen Conference Room" Register now 🔗 https://lnkd.in/dYY7_2sm Secure your spot now and stay ahead in the ever-evolving landscape of advanced manufacturing! #CencoraPharmaLex #IFPAC2024 #AdvancedManufacturing #Innovation
To view or add a comment, sign in
-
-
AZD5462 - a drug candidate recently highlighted by Drug Hunter is a potent and selective pharmacological mimetic of relaxin H2 signaling that is a potential treatment for heart failure. We have created a set of analogs for this molecule! https://buff.ly/3Qd7z6k AZD5462 is a potential treatment for heart failure. It is a small molecule mimic of the relaxin H2 signal on RXFP1, which is effective in animal models. In studies in cynomolgus monkeys, a sustained improvement in cardiac function was observed. AZD5462 was shown to be safe and well tolerated in Phase I clinical trials in healthy volunteers. Discover a wide array of in-stock and customizable molecules tailored to your needs. Got interested? Reach out to us at info(AT)chem-space.com #chemspace #openscience #research #science #drugdiscovery #chemicals #medicinalchemistry #drugdevelopment #chemistry #researchanddevelopment #search #chemicalindustry #science #structures
To view or add a comment, sign in
-
-
EU labs have learned many new tricks this past year with the IVDR rollout – Kudos to you on European Lab Day! https://lnkd.in/e8BXjwz8. This year has brought a steep learning curve for EU diagnostic labs as they work toward compliance for their in-house tests, among other hoops posed by the IVDR. Platomics aims to make lab life easier by automating quality and compliance. Our platform connects labs with manufacturers and other key stakeholders to simplify IVDR. We believe in maintaining a compliant space for innovative diagnostics. Watch our IVDReady webinars: https://lnkd.in/ewHphkcz #ivdready #ivdr #regulatory
Lab Day 2023
eflm.eu
To view or add a comment, sign in